Starfire Investment Advisers’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$785K Hold
12,141
0.37% 67
2020
Q1
$667K Sell
12,141
-350
-3% -$21.3K 0.37% 71
2019
Q4
$808K Hold
12,491
0.31% 73
2019
Q3
$707K Hold
12,491
0.29% 81
2019
Q2
$751K Hold
12,491
0.34% 71
2019
Q1
$814K Hold
12,491
0.37% 63
2018
Q4
$778K Buy
12,491
+641
+5% +$43.3K 0.42% 55
2018
Q3
$871K Sell
11,850
-641
-5% -$46K 0.43% 50
2018
Q2
$839K Hold
12,491
0.42% 56
2018
Q1
$779K Buy
+12,491
New +$822K 0.41% 59
2017
Q4
Sell
-13,120
Closed -$857K 203
2017
Q3
$857K Sell
13,120
-385
-3% -$24.3K 0.52% 43
2017
Q2
$847K Sell
13,505
-625
-4% -$37.5K 0.5% 46
2017
Q1
$849K Sell
14,130
-790
-5% -$46.2K 0.46% 51
2016
Q4
$836K Sell
14,920
-585
-4% -$33.7K 0.48% 48
2016
Q3
$956K Hold
15,505
0.56% 44
2016
Q2
$982K Hold
15,505
0.68% 37
2016
Q1
$932K Sell
15,505
-4,020
-21% -$246K 0.61% 40
2015
Q4
$1.37M Hold
19,525
0.94% 26
2015
Q3
$1.3M Hold
19,525
0.95% 29
2015
Q2
$1.53M Hold
19,525
1.01% 29
2015
Q1
$1.49M Buy
+19,525
New +$1.44M 0.98% 28

Other funds holding PJP

Starfire Investment Advisers's PJP Position: Q2 2020 in Review

Starfire Investment Advisers held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2020 at 12,141 shares worth $785K. The position accounts for 0.37% of the portfolio, ranked #67.

Starfire Investment Advisers first reported a position in PJP in Q1 2015 and has held it in 21 quarters since. The position peaked at $1.53M in Q2 2015. 86 funds tracked by Wall St. Rank hold PJP as of Q2 2020.

  • Starfire Investment Advisers held 12,141 shares of Invesco Pharmaceuticals ETF worth $785K as of Q2 2020.
  • Starfire Investment Advisers left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2020.
  • Invesco Pharmaceuticals ETF made up 0.37% of Starfire Investment Advisers's portfolio in Q2 2020, its #67 holding.
  • Starfire Investment Advisers first reported a position in Invesco Pharmaceuticals ETF in Q1 2015 and has held it in 21 quarters since.
  • Starfire Investment Advisers's Invesco Pharmaceuticals ETF position peaked at $1.53M in Q2 2015.
  • 86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2020.

Based on Starfire Investment Advisers's 13F filing for Q2 2020, filed 9 Jul 2020.